New Research Unveils Potential Causes of Infertility
Even in the best-case scenario, where fertility clinics transfer chromosomally normal embryos into a woman's uterus, the procedure only results in a live birth half the time. Some embryo transfers lead to pregnancy, followed by miscarriage, while in 30 to 35% of cases, the embryo fails to implant in the uterus at all.
For decades, fertility research has primarily focused on embryo quality, but recent studies suggest that the issue might lie elsewhere: within the uterus itself. A groundbreaking study conducted by Rutgers Health and Michigan State University provides compelling evidence supporting this theory.
The research, published in JCI Insight, identified 556 genes, primarily found in gland cells of the uterine lining (endometrium), that are expressed differently in fertile women compared to those struggling with infertility. This discovery sheds light on the uterus's role in the reproductive process.
Nataki Douglas, an associate professor of obstetrics, gynecology, and reproductive health at Rutgers New Jersey Medical School, led the study. She explained, "This study was one of the first to examine the menstrual cycle in fertile women and understand the endometrium's transformation, particularly its receptivity to embryo attachment at a fundamental level."
The researchers faced challenges in sampling endometrial tissue just before embryo transfer after in vitro fertilization, as such procedures could disrupt early pregnancy. Instead, they enrolled 30 patients from University Hospital in Newark, all with regular menstrual cycles and proven fertility. These participants used ovulation predictor kits and coordinated with the research team to ensure endometrial biopsies were taken at specific phases of the menstrual cycle. Blood hormone levels and microscopic examination confirmed the timing, ensuring a rigorous approach.
To analyze the endometrium's dynamic biology, the researchers employed two sequencing techniques: one measuring gene activity in the tissue as a whole and another examining it on a cellular level. Both methods revealed a consistent pattern: the most significant molecular changes occurred during the mid-secretory phase of the menstrual cycle, typically the window for embryo implantation.
The most remarkable alterations were observed in specialized cells within uterine glands, which produce molecules believed to nourish the embryo and facilitate implantation. While previous research had established the significance of these glands in mice and sheep, this study provides the first human evidence of the glandular epithelium's crucial role. The authors noted that the correlation between their findings from predominantly Black and Hispanic patients and those from mostly white patients in past research suggests that similar factors contribute to infertility across different racial groups.
Building on these insights, the researchers developed a 556-gene signature named the Glandular Epithelium Receptivity Module (GERM). When applied to published datasets, the GERM score consistently indicated lower levels in women with recurrent implantation failure or pregnancy loss compared to fertile controls.
Despite the promising findings, the research is still far from clinical application. Douglas explained, "Our next steps involve narrowing down the gene list to a more manageable size and prospectively recruiting patients with implantation failure to determine if the signature can predict outcomes."
The ultimate goal is to enable clinicians to identify when a patient's endometrium is not functioning optimally and, in the future, to address any identified issues. Douglas added, "Once we can pinpoint the at-risk individuals and the critical genes within this 556-gene list, we might be able to develop synthetic approaches to add specific proteins, potentially leading to therapeutic interventions."
This research opens up exciting possibilities for understanding and treating infertility, offering a more comprehensive approach to reproductive health.
